Vasomune Therapeutics is at the 38th J.P. Morgan Healthcare Conference

Ronald Zahoruk
January 15, 2020
Uncategorized

Vasomune Therapeutics is currently attending the 38TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

Close Menu

You Might Also Like

Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreement to Advance an Innovative Platform Targeting Vascular Leakage

Preventing the flu: Researchers looking for a new approach

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

About

Vasomune Therapeutics 2020 © All Rights Reserved.